Abstract | PURPOSE: Although metabolic changes make diagnosis of insulinoma relatively easy, surgical removal is hampered by difficulties in locating it, and there is no efficient treatment for malignant insulinoma. We have previously shown that the high density of glucagon-like peptide-1 receptors (GLP-1R) in human insulinoma cells provides an attractive target for molecular imaging and internal radiotherapy. In this study, we investigated the therapeutic potential of [Lys(40)(Ahx- DTPA-(111)In)NH(2)]- Exendin-4, an (111)In-labeled agonist of GLP-1, in a transgenic mouse model of human insulinoma. EXPERIMENTAL DESIGN: [Lys(40)(Ahx- DTPA-(111)In)NH(2)]- Exendin-4 was assessed in the Rip1Tag2 mouse model of pancreatic beta-cell carcinogenesis, which exhibits a GLP-1R expression comparable with human insulinoma. Mice were injected with 1.1, 5.6, or 28 MBq of the radiopeptide and sacrificed 7 days after injection. Tumor uptake and response, the mechanism of action of the radiopeptide, and therapy toxicity were investigated. RESULTS:
Tumor uptake was >200% injected activity per gram, with a dose deposition of 3 Gy/MBq at 40 pmol [Lys(40)(Ahx- DTPA-(111)In)NH(2)]- Exendin-4. Other GLP-1R-positive organs showed > or =30 times lower dose deposition. A single injection of [Lys(40)(Ahx- DTPA-(111)In)NH(2)]- Exendin-4 resulted in a reduction of the tumor volume by up to 94% in a dose-dependent manner without significant acute organ toxicity. The therapeutic effect was due to increased tumor cell apoptosis and necrosis and decreased proliferation. CONCLUSIONS:
|
Authors | Andreas Wicki, Damian Wild, Daniel Storch, Christian Seemayer, Martin Gotthardt, Martin Behe, Stefan Kneifel, Michael J Mihatsch, Jean-Claude Reubi, Helmut R Mäcke, Gerhard Christofori |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 13
Issue 12
Pg. 3696-705
(Jun 15 2007)
ISSN: 1078-0432 [Print] United States |
PMID | 17575235
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- (Lys(40)(Ahx-DTPA-111In)NH2)exendin-14
- GLP1R protein, human
- Glp1r protein, mouse
- Glucagon-Like Peptide-1 Receptor
- Indium Radioisotopes
- Organometallic Compounds
- Peptides
- Radiopharmaceuticals
- Receptors, Glucagon
- Pentetic Acid
|
Topics |
- Animals
- Cell Proliferation
(drug effects)
- Female
- Glucagon-Like Peptide-1 Receptor
- Indium Radioisotopes
(pharmacokinetics, therapeutic use)
- Insulinoma
(diagnostic imaging, metabolism)
- Male
- Mice
- Mice, Transgenic
- Organometallic Compounds
(pharmacokinetics, therapeutic use)
- Pancreatic Neoplasms
(diagnostic imaging, metabolism)
- Pentetic Acid
(pharmacokinetics, therapeutic use)
- Peptides
(pharmacokinetics, therapeutic use)
- Radionuclide Imaging
- Radiopharmaceuticals
(pharmacokinetics, therapeutic use)
- Receptors, Glucagon
(metabolism)
- Tissue Distribution
|